XRAY Form 4: DENTSPLY SIRONA director increases stake to 57,343 shrs
Rhea-AI Filing Summary
DENTSPLY SIRONA Inc. director reports open-market stock purchase
A director of DENTSPLY SIRONA Inc. (XRAY) reported buying common stock in the company. On 11/24/2025, the reporting person purchased 9,337 shares of common stock at a price of $10.71 per share, in an open-market transaction coded as a purchase. After this transaction, the director beneficially owns 57,342.925 shares of DENTSPLY SIRONA common stock, held directly. This filing is a routine Form 4 disclosure of insider trading activity required under U.S. securities regulations.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 9,337 | $10.71 | $100K |
FAQ
What insider transaction did DENTSPLY SIRONA (XRAY) report on this Form 4?
The filing reports that a director of DENTSPLY SIRONA Inc. (XRAY) purchased 9,337 shares of common stock in an open-market transaction.
What is the relationship of the reporting person to DENTSPLY SIRONA (XRAY)?
The reporting person is identified as a Director of DENTSPLY SIRONA Inc.
Were any derivative securities reported in this DENTSPLY SIRONA (XRAY) Form 4?
The section for derivative securities is present but does not list any specific derivative transactions in the provided content.
Is this DENTSPLY SIRONA (XRAY) Form 4 filed for one or multiple reporting persons?
The document indicates it is a Form filed by One Reporting Person.
AI-generated analysis. How Rhea-AI works. Not financial advice.